Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
injected arm still hurts/ pain; injected arm has limited mobility; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis. In OCT-2024, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: injected arm still hurts/ pain) and injected limb mobility decreased (Verbatim: injected arm has limited mobility). The outcome of the pain in arm and injected limb mobility decreased were not resolved. It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to Shingrix. It was unknown if the company considered the pain in arm and injected limb mobility decreased to be related to Shingrix. Additional Information: GSK Receipt Date: 21-JAN-2025 Patient was the reporter. Patient had the Shingrix vaccine in October 2024, and his/her injected arm still hurt and had limited mobility. He/she read that he/she was supposed to take pain relievers, but patient was asking whether they need to take it forever. He/she did not want to take the second dose because the pain continued. Patient never had any reaction to any other vaccine, although he/she vaccinated on a recommended schedule for any and all other vaccines.